Sign up to save your podcasts
Or
Share Under the microscope: SomnoMed (ASX:SOM) - Neil Verdal-Austin, Chief Executive Officer
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Under the microscope: SomnoMed (ASX:SOM) - Neil Verdal-Austin, Chief Executive Officer
SomnoMed (ASX:SOM) Chief Executive Officer Neil Verdal-Austin, joins Morgans Research Analyst Iain Wilkie to discuss the company's 1H20 results, and share some insight into what to expect in the next 12 months.
View all episodes
By Morgans Financial LimitedSomnoMed (ASX:SOM) Chief Executive Officer Neil Verdal-Austin, joins Morgans Research Analyst Iain Wilkie to discuss the company's 1H20 results, and share some insight into what to expect in the next 12 months.